BMS Reports EXCALIBER-RRMM Results for ZENBEXUS
PRINCETON, N.J. — September 26, 2026 Bristol Myers Squibb announced the first presentation of results from the pivotal Phase...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
PRINCETON, N.J. — September 26, 2026 Bristol Myers Squibb announced the first presentation of results from the pivotal Phase...
PRINCETON, N.J. — September 23, 2026 ANI Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted...
Miami Lakes, Florida, U.S., September 21, 2026 Cordis has announced that the U.S. Food and Drug Administration (FDA) has...
CLEVELAND, Ohio — September 18, 2026 Abeona Therapeutics congratulated Ultragenyx Pharmaceutical on the U.S. FDA approval of FAYUVI™ (rebisufligene...
Bridgewater, New Jersey, U.S., September 21, 2026 Insmed has announced that the U.S. Food and Drug Administration (FDA) has...
Indianapolis, Indiana, September 18, 2026 Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA)...
Columbus, Ohio, September 18, 2026 Andelyn Biosciences has announced a major milestone in commercial gene therapy manufacturing following the...
Novato, California, U.S., September 17, 2026 Ultragenyx Pharmaceutical Inc. announced that the U.S. Food and Drug Administration (FDA) has...
Abu Dhabi, UAE, September 17, 2026 Insilico Medicine has announced a new milestone from its UAE-based AI drug discovery...
New York, New York, September 17, 2026 DarioHealth Corp. has announced a new contract with one of New Jersey’s...
